MR Spectroscopy Detects Lipid Peaks in Cerebrotendinous Xanthomatosis

References

1. 1.↵
   1. Barkhof F,
   2. Verrips A,
   3. Wesseling P,
   4. et al

   . Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology 2000;217:869–76

   PubMedWeb of Science
2. 2.↵
   1. Verrips A,
   2. Hoefsloot LH,
   3. Steenbergen GC,
   4. et al

   . Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain 2000;123:908–19

   Abstract/FREE Full Text
3. 3.↵
   1. Federico A,
   2. Dotti MT

   . Cerebrotendinous xanthomatosis: clinical manifestations, diagnostic criteria, pathogenesis, and therapy. J Child Neurol 2003;18:633–38

   Abstract/FREE Full Text
4. 4.↵
   1. Gallus GN,
   2. Dotti MT,
   3. Federico A

   . Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene. Neurol Sci 2006;27:143–49

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Berginer VM,
   2. Gross B,
   3. Morad K,
   4. et al

   . Chronic diarrhea and juvenile cataracts: think cerebrotendinous xanthomatosis and treat. Pediatrics 2009;123:143–47

   Abstract/FREE Full Text
6. 6.↵
   1. De Stefano N,
   2. Dotti MT,
   3. Mortilla M,
   4. et al

   . Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001;124:121–31

   Abstract/FREE Full Text
7. 7.↵
   1. Provencher SW

   . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Pilo de la Fuente B,
   2. Ruiz I,
   3. Lopez de Munain A,
   4. et al

   . Cerebrotendinous xanthomatosis: neuropathological findings. J Neurol 2008;255:839–42

   CrossRefPubMed
9. 9.↵
   1. Gillard JH,
   2. Waldman A,
   3. Barker P

   . Clinical MR neuroimaging: diffusion, perfusion, and spectroscopy. Cambridge, UK: Cambridge University Press; 2005:7–26
10. 10.↵
    1. Willemsen MA,
    2. Van Der Graaf M,
    3. Van Der Knaap MS,
    4. et al

    . MR imaging and proton MR spectroscopic studies in Sjogren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 2004;25:649–57

    Abstract/FREE Full Text
11. 11.↵
    1. Oostendorp M,
    2. Engelke UF,
    3. Willemsen MA,
    4. et al

    . Diagnosing inborn errors of lipid metabolism with proton nuclear magnetic resonance spectroscopy. Clin Chem 2006;52:1395–405

    Abstract/FREE Full Text
12. 12.↵
    1. Maheshwari SR,
    2. Fatterpekar GM,
    3. Castillo M,
    4. et al

    . Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 2000;21:434–51

    CrossRefPubMed